Background Autologous blood therapy (ABT) has been used to treat atopic dermatitis (AD) for over a century, even though evidence supporting its efficacy is lacking. We aimed to investigate the effectiveness and safety of autologous serum intramuscular injection (ASIM), which is a modified form of ABT, in treating mild-to-moderate AD.
Methods This study was a 12-week, open-label, prospective, uncontrolled trial. Following a 4-week run-in period, 22 out of 25 screened patients received ASIM once a week for 4 weeks in conjunction with standard treatment. The primary outcome measure was the Eczema Area and Severity Index (EASI), while the secondary outcomes included the Scoring Atopic Dermatitis (SCORAD) score, Dermatologic Life Quality Index (DLQI), and patient ratings of pruritus, sleep difficulty, disease status, and treatment effectiveness. Safety parameters were also assessed.
Results EASI scores showed a non-statistically significant trend toward improvement during ASIM intervention. Patients with at least a 50% improvement in the EASI score at 4 weeks were older and had lower peripheral eosinophil counts (p<0.05). Secondary endpoints, including the SCORAD score, pruritus, sleep difficulty, and DLQI, demonstrated statistically significant improvements at week 4 compared to baseline (p<0.05). No significant adverse reactions were observed.
Conclusions This pioneering study suggests that repeated ASIM may improve the clinical symptoms of mild-to-moderate AD, particularly in terms of pruritus and overall quality of life. However, further research with a larger sample size is required to establish the clinical significance of these findings.
Citations
Citations to this article as recorded by
What are the clinical usefulness and scientific value of intramuscular injection of autologous serum (autologous serum therapy) in patients with atopic dermatitis? Dong-Ho Nahm Kosin Medical Journal.2024; 39(1): 1. CrossRef
Clinicians and healthcare decision-makers conduct their clinical practice based on the results of clinical trials. However, some health problems remain unresolved; in such cases, further research is required. To ensure reliable research results, it is important to understand the study design and conduct well-designed clinical trials. Many study designs can be chosen within the two broad categories of observational and interventional. Clinical studies have a variety of designs, including case series, case-control, cross-sectional, and prospective and retrospective cohort studies. Well-designed clinical studies can clarify important differences between treatment options and provide data on long-term drug efficacy and safety. Interpreting the results of clinical trials can be difficult because weaknesses in research design, data collection methods, analytic methods, and reporting can compromise their value and usefulness. However, although randomized controlled trials are limited owing to ethical and practical issues, they are optimal for investigating the effects of therapy and establishing causality. Here we present an overview of different clinical research designs and review their advantages and limitations.
Citations
Citations to this article as recorded by
Common statistical methods used in medical research Hye Jin Yang, Hye Sun Lee Kosin Medical Journal.2025; 40(1): 21. CrossRef
Mastering CT-based radiomic research in lung cancer: a practical guide from study design to critical appraisal Ashley Horne, Azadeh Abravan, Isabella Fornacon-Wood, James P B O’Connor, Gareth Price, Alan McWilliam, Corinne Faivre-Finn British Journal of Radiology.2025; 98(1169): 653. CrossRef
Postoperative scar management Jinyong Shin, Yoonsoo Kim, Hongil Kim, Jinhyung Park, Hyungsuk Yi Kosin Medical Journal.2025; 40(2): 96. CrossRef
Brain hemorrhage in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports Bangju Kim, Hyun Joon Park, Sang Uk Lee, Kwang Il Seo, Jung Wook Lee, Sumin Jo, Jun Yeb Nam Kosin Medical Journal.2025; 40(2): 150. CrossRef
Gastric cancer and metabolic syndrome Hyeong Ho Jo Kosin Medical Journal.2024; 39(1): 26. CrossRef
Clinical efficacy and safety of autologous serum intramuscular injection in patients with mild-to-moderate atopic dermatitis: a prospective, open-label, uncontrolled study Gil-Soon Choi, Jong Bin Park, Young-Ho Kim, Hee-Kyoo Kim Kosin Medical Journal.2024; 39(1): 51. CrossRef
Changes in parents’ health concerns by post-preterm birth period in South Korea: a cross-sectional study Yu Jin Jung, Hun Ha Cho Child Health Nursing Research.2024; 30(2): 118. CrossRef
Current understanding of modulated electro-hyperthermia in cancer treatment Sungmin Kim, Jesang Yu, Jihun Kang, Yunkyung Kim, Taek Yong Ko Kosin Medical Journal.2024; 39(3): 160. CrossRef
Basic knowledge of endoscopic retrograde cholangiopancreatography Jung Wook Lee Kosin Medical Journal.2023; 38(4): 241. CrossRef
Evaluation of automated calibration and quality control processes using the Aptio total laboratory automation system Namhee Kim, Yein Kim, Jeongeun Park, Jungsoo Choi, Hyunyong Hwang Kosin Medical Journal.2022; 37(4): 342. CrossRef
The effects of rebamipide, sucralfate, and rifaximin against inflammation and apoptosis in radiation-induced murine intestinal injury Won Moon, Sangwook Lim, Yeonsoon Jung, Yuk Moon Heo, Seun Ja Park, Moo In Park, Sung Eun Kim, Jae Hyun Kim, Kyoungwon Jung Kosin Medical Journal.2022; 37(4): 320. CrossRef